Cite Filings / STOK / 0001193125-26-113933
Feed Companies Filings Check
Sign in
S-3ASR

Registration Statement

Stoke Therapeutics, Inc. · Filed 2026-03-18 · Acc 0001193125-26-113933

Documents 1

  • S-3ASR Registration Statement , d122133ds3asr.htm

Around this filing

  • 2026-03-18 S-3ASR Registration Statement
  • 2026-03-17 4 GENERAL COUNSEL & CORP SEC acquired 25,475 shares (option exercise)
  • 2026-03-17 4 CHIEF MEDICAL OFFICER acquired 33,850 shares (option exercise)
  • 2026-03-17 4 Chief Patient Officer acquired 10,000 shares (option exercise)
  • 2026-03-17 4 Director acquired 61,750 shares (option exercise)
  • 2026-03-17 4 Director sold 605 shares at $36.80 ($22,264)
  • 2024-10-09 S-3ASR Registration Statement

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading d122133ds3asr.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…